Abiopharma

NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates

Perrigo Company plc (PRGO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - Robbins Geller Rudman & Dowd LLP

Data from Genprex’s Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

NervGen Pharma Announces Expanded CONNECT SCI Study Data Demonstrating Unprecedented Durable Improvement in Function, Independence, and Quality of Life in Chronic Spinal Cord Injury

Bausch Health Notification

Lineage Achieves First Milestone Under Worldwide Collaboration Agreement with Genentech

Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

Veeva Announces Expanded Partnership with Roche

QuidelOrtho Corporation - QuidelOrtho To Participate In Upcoming Investor Conferences